The investigators explored the relationships between headache frequency and characteristics, medication use, and quality of life in patients with chronic migraine and medication overuse headache.
The approval was based on data from a study that compared 2 different maintenance dosages of Panzyga in 142 adults with CIDP.
A chart review examines the effectiveness and tolerability of low-dose naltrexone to relieve symptoms of neuropathic corneal pain.
Findings from an adolescent study showed that 46.8% of treated attacks were successfully resolved without the use of any acute rescue medication.
A team of researchers conducted a systematic review to examine the association between migraine and lipid profile differences.
Researchers did a systematic review of guidelines covering a 13-year period to evaluate recommended rehabilitative interventions for neuropathic pain.
Can nonviral gene delivery of hepatocyte growth factor reduce pain in patients with DPN and modify progression of the disorder?
Access to primary care is limited for patients taking opioids for chronic pain, particularly for patients with histories suggestive of aberrant use of opioids.
Researchers assessed safety reports on erenumab, galcanezumab, and fremanezumab, and conducted disproportionality analyses regarding suspected adverse drug reactions during pregnancy and lactation.
Patients with migraine, headache, or occipital neuralgia who underwent greater occipital nerve decompression surgery had abnormal tissue structure.